BioSpace News Archive

Aviv Clinics highlights a groundbreaking new study that has been published in Scientific Reports, featuring a promising treatment for long COVID symptoms.

AmbioPharm, a global peptide CDMO, is a key partner in peptide manufacturing and development for ONL Therapeutics (ONL), a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease.

The Global Mobile Health (mHealth) Market size is estimated to reach USD 310.37 billion by 2027 from USD 51.90 Billion in 2021, delivering a CAGR of 29.5%, according to a new report by Reports and Data.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer’s disease mouse model (aged APP/PS1+/- mice), supporting the therapeutic cognitive potential of HT-ALZ after chronic oral dosing.

The global concierge medicine market size was USD 10.8 Billion in 2021 and is expected to register a revenue CAGR of 5.9% during the forecast period, according to latest analysis by Emergen Research.

Halberd Corporation (OTC Pink: HALB) This past quarter has witnessed some very significant technical and organizational achievements by the Halberd team.

The U.S. Food and Drug Administration issued warning letters to four companies for illegally selling honey-based products that may pose a significant health risk to consumers.

The global Hepatitis B Vaccines market size is estimated to be worth US$ 1021.8 million in 2021 and is forecast to a readjusted size of US$ 1159.5 million by 2030 with a CAGR of 1.8% during the forecast period 2022-2030.

The global Pharmaceutical Ethanol market size is estimated to be worth US$ 1224 million in 2021 and is forecast to a readjusted size of US$ 1091.8 million by 2030 with a CAGR of -1.6% during the forecast period 2022-2030.

The global Ceftriaxone Sodium market size is estimated to be worth US$ 264.2 million in 2021 and is forecast to a readjusted size of US$ 217.6 million by 2030 with a CAGR of -2.7% during the forecast period 2022-2030.